Neurotoxic (+)-methamphetamine treatment in rats increases brain-derived neurotrophic factor and tropomyosin receptor kinase B (TrkB) expression in multiple brain regions

Division of Neurology, Department of Pediatrics, Cincinnati Children's Research Foundation and University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Neuroscience (Impact Factor: 3.36). 03/2011; 184:164-71. DOI: 10.1016/j.neuroscience.2011.03.045
Source: PubMed


Methamphetamine (MA) is an abused stimulant which can result in cognitive deficits and monoamine depletions. Animal models of neurotoxic MA exposure show reductions in dopamine, serotonin, and their associated transporters. MA abuse can result in long-term attention, working memory, and executive function deficits in humans and deficits in route-based egocentric learning, novel object recognition, and novel odor preference in rodents. MA has also been shown to affect brain-derived neurotrophic factor (BDNF) in humans and rodents. This experiment examined the effects of a MA binge dosing regimen (10 mg/kg x 4 at 2 h intervals, s.c.) in Sprague-Dawley rats on BDNF, tropomyosin receptor kinase B (TrkB), and tyrosine hydroxylase (TH) mRNA expression, and plasma corticosterone. Tissues were collected 1, 7, and 24 h following the last MA dose. Expression of BDNF and TrkB mRNA was analyzed using in situ hybridization with cRNA probes. Frontal, parietal, and entorhinal cortical BDNF mRNA expression were increased by MA exposure at all time-points. Increases in BDNF mRNA were also seen in the hippocampal CA1, prefrontal cortex (PFC), piriform cortex, and locus coeruleus but only at specific times. TrkB mRNA expression was modified in several subregions of the hippocampus as well as in PFC and striatum. TH mRNA was increased at the 1 h time-point in the substantia nigra pars compacta with no differences noted at the other times. Corticosterone levels were increased at all three time-points. The findings suggest that BDNF and its receptor may be upregulated as a compensatory mechanism after MA exposure.

Download full-text


Available from: Tori L Schaefer, Oct 05, 2015
1 Follower
20 Reads
  • Source
    • "Large doses of methamphetamine result in neuronal toxicity and the induction of cell death throughout the brain [16]. However, low dose methamphetamine may be protective after oxygen glucose deprivation by decreasing excitatory synaptic potential, and prevents cell death by modulating cytokines and neurotrophic factors [17], [18]. Recently, in a lateral fluid percussion injury model of rat, low dose methamphetamine treatment at three hours after TBI significantly increased the presence of immature neurons, and reduced apoptotic cell death, as well as improved both behavioral and cognitive dysfunctions [15]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We assessed the effects of low dose methamphetamine treatment of traumatic brain injury (TBI) in rats by employing MRI, immunohistology, and neurological functional tests. Young male Wistar rats were subjected to TBI using the controlled cortical impact model. The treated rats (n = 10) received an intravenous (iv) bolus dose of 0.42 mg/kg of methamphetamine at eight hours after the TBI followed by continuous iv infusion for 24 hrs. The control rats (n = 10) received the same volume of saline using the same protocol. MRI scans, including T2-weighted imaging (T2WI) and diffusion tensor imaging (DTI), were performed one day prior to TBI, and at 1 and 3 days post TBI, and then weekly for 6 weeks. The lesion volumes of TBI damaged cerebral tissue were demarcated by elevated values in T2 maps and were histologically identified by hematoxylin and eosin (H&E) staining. The fractional anisotropy (FA) values within regions-of-interest (ROI) were measured in FA maps deduced from DTI, and were directly compared with Bielschowsky's silver and Luxol fast blue (BLFB) immunohistological staining. No therapeutic effect on lesion volumes was detected during 6 weeks after TBI. However, treatment significantly increased FA values in the recovery ROI compared with the control group at 5 and 6 weeks after TBI. Myelinated axons histologically measured using BLFB were significantly increased (p<0.001) in the treated group (25.84±1.41%) compared with the control group (17.05±2.95%). Significant correlations were detected between FA and BLFB measures in the recovery ROI (R = 0.54, p<0.02). Methamphetamine treatment significantly reduced modified neurological severity scores from 2 to 6 weeks (p<0.05) and foot-fault errors from 3 days to 6 weeks (p<0.05) after TBI. Thus, the FA data suggest that methamphetamine treatment improves white matter reorganization from 5 to 6 weeks after TBI in rats compared with saline treatment, which may contribute to the observed functional recovery.
    PLoS ONE 04/2013; 8(4):e61241. DOI:10.1371/journal.pone.0061241 · 3.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Human adult olfactory epithelium contains neural progenitors (hONPs) which replace damaged cellular components throughout life. Methods to isolate and expand the hONPs which form neurospheres in vitro have been developed in our laboratory. In response to morphogens, the hONPs differentiate along several neural lineages. This study optimized conditions for the differentiation of hONPs towards dopaminergic neurons. The hONPs were treated with Sonic hedgehog (Shh), in the presence or absence of retinoic acid (RA) and/or forskolin (FN). Transcription factors (nurr1, pitx3 and lmx1a) that promote embryonic mouse or chicken dopaminergic development were employed to determine if they would modulate lineage restriction of these adult human progenitors. Four expression vectors (pIRES-pitx3-nurr1, pLN-CX2-pitx3, pLNCX2-nurr1 and pLNCX2-lmx1a) were transfected into the hONPs, respectively. Transcription factor expression and the rate-limiting enzyme in dopamine synthesis tyrosine hydroxylase (TH) were detected in the transfected cells after 4 month-selection with G418, indicating transfected hONPs were stably restricted towards a dopaminergic lineage. Furthermore, a dopamine enzyme immunoassay (EIA) was employed to detect the synthesis and release of dopamine. The most efficient transfection paradigm was determined. Several neurotrophic factors were detected in the pre-transfected hONPs which have potential roles in the maintenance, survival and proliferation of dopaminergic neurons. Therefore the effect of transfection on the neurotrophin synthesis was examined. Transfection did not alter synthesis. The use of olfactory progenitors as a cell-based therapy for Parkinson’s disease (PD) would allow harvest without invasive surgery, provide an autologous cell population, eliminate need for immunosuppression and avoid the ethical concerns associated with embryonic tissues. This study suggests that specific transcription factors and treatment with morphogens can restrict human adult olfactory-derived progenitors to a dopaminergic neuronal lineage. Future studies will evaluate the utility of these unique cells in cell-replacement paradigms for the treatment of PD like animal models.
    Stem Cell Discovery 10/2011; 1(3):29-43. DOI:10.4236/scd.2011.13004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dopamine within caudate-putamen is essential for the integration and regulation of motor and cognitive functions such as learning and memory. Drugs of abuse produce complex adaptations in that subcortical structure and there has been a resurgence of interest in the role of caudate-putamen in drug addiction based on its likely participation in habit-based learning that may drive compulsive behaviour. Astrocytes playing a major role in the clearance of neurotransmitters, including dopamine, by uptake and inactivation also contribute to the synaptic and structural plasticity associated with drug addiction. Methamphetamine is a powerful indirect Comentário [u1]: , Frederico C. Pereira, Sofia Viana, Patrícia Mendes et al. 2 sympathicomimetic drug of abuse with potent addictive and neurotoxic properties, for which there is no approved pharmacological treatment. This stimulant evokes a chronic reduction in dopaminergic neuronal function as well as astrogliosis in caudate-putamen underlying chemical, structural and metabolic changes in both in human addicts and in pre-clinical models. The purpose of the present review is to provide pre-clinical as well as human studies to highlight the impact of methamphetamine abuse on dopamine homeostasis and astrocytic activation within the caudate-putamen.
    Horizons in Neuroscience Research. Volume 7, 04/2012: chapter Chapter 1 - Caudate-Putamen: Dopamine Homeostasis and Astrocyte Activation in Methamphetamine Abuse: pages 1-28; Nova Science Publishers.
Show more